Balance Labs (BLNC) Common Equity (2014 - 2026)

Balance Labs has reported Common Equity for 13 years, with the latest figure at -$2.9 million in Q1 2026.

• For the quarter ending Q1 2026, Common Equity rose 43.49% year-over-year to -$2.9 million; the trailing twelve-month figure through Mar 2026 stood at -$2.9 million (up 43.49% YoY), and the FY2025 full-year result was -$3.4 million, up 33.42% from the prior year.
• Common Equity for Q1 2026 stood at -$2.9 million, up from -$3.4 million in the prior quarter.
• The five-year high for Common Equity was -$2.9 million in Q1 2026, with the low at -$8.7 million in Q3 2025.
• Historically, Common Equity has averaged -$4.6 million across 5 years, with a median of -$4.4 million in 2023.
• Annual changes were most pronounced in 2022 — Common Equity sank 2451.9% — and 2026, when it jumped 43.49%.
• Balance Labs' Common Equity stood at -$4.2 million in 2022, then slipped by 9.17% to -$4.5 million in 2023, then dropped by 11.63% to -$5.1 million in 2024, then soared by 33.42% to -$3.4 million in 2025, then rose by 15.01% to -$2.9 million in 2026.
• The last three Common Equity figures came in at -$2.9 million (Q1 2026), -$3.4 million (Q4 2025), and -$8.7 million (Q3 2025), per Business Quant data.